Publication | Closed Access

Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents

DerivativesMedicineAntiviral Drug DevelopmentAntiviral TherapyHepatitisBiological EvaluationAntiviral DrugPharmacologyAntiviral CompoundDrug Discovery